ESR1 and breast cancer: Triple-negative breast cancer (TNBC), classified as a subtype within the realm of breast cancer, is identified via immunohistochemistry by the lack of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth receptor 2 (HER2).